Factory Price China Anti -Villin Rabbit Polyclonal Primary Antibodies

inkcazelo emfutshane:


  • Ixesha lovavanyo:Imizuzu eyi-10-15
  • Ixesha elisebenzayo:Iinyanga ezingama-24
  • Ukuchaneka:Ngaphezulu kwe-99%
  • Inkcazo:1/25 uvavanyo / ibhokisi
  • Ubushushu bokugcina :2℃-30℃
  • :
  • Iinkcukacha zeMveliso

    Iithegi zeMveliso

    Sithatha "i-customer-friendly, i-oriented-orientation, indibaniselwano, into entsha" njengeenjongo. "Inyaniso kunye nokunyaniseka" lulawulo lwethu olufanelekileyo kwiFactory Price China Anti -Villin Rabbit PolyclonalIi-Antibodies eziphambili, Siya kubamkela ngeentliziyo ezipheleleyo bonke abathengi abasuka kushishino aba babini ekhaya naphesheya ukuba basebenzisane ngesandla, kwaye bavelise ikamva eliqaqambileyo elibonakalayo ngokudibeneyo.
    Sithatha "i-customer-friendly, i-oriented-orientation, indibaniselwano, into entsha" njengeenjongo. "Inyaniso kunye nokunyaniseka" lulawulo lwethu olufanelekileyoChina Antibody Primary, Ii-Antibodies eziphambili, Iqela lethu lobunjineli abaqeqeshiweyo liya kulungiswa ngokubanzi ukukusebenzela ukubonisana kunye nempendulo. Siye sakwazi ukukubonelela ngeesampulu simahla ukuhlangabezana neemfuno zakho. Iinzame ezingcono kakhulu ziya kuveliswa ukukuzisa eyona nkonzo ilungileyo kunye norhwebo. Xa unomdla kwishishini kunye neemveliso zethu, kufuneka uthethe nathi ngokusithumelela ii-imeyile okanye usitsalele umnxeba ngokukhawuleza. Kumzamo wokwazi iimveliso zethu kunye nenkampani eyongezelelweyo, ungeza kumzi-mveliso wethu ukuze uyijonge. Siya kwamkela iindwendwe ezivela kwihlabathi liphela kwishishini lethu ukwenza ubudlelwane beshishini kunye nathi. Nceda uzive ukhululekile ukuthetha nathi ngamashishini amancinci kwaye sikholelwa ukuba siza kwabelana ngamava orhwebo angcono kunye nabo bonke abarhwebi bethu.
    CEA

    ikhola_conew1

     

    Iimveliso Iinkcukacha ikhowudi iyunithi uluhlu lomgca uluhlu lwereferensi Uluhlu lomgca
    Ikhithi yokuxilonga yeCarcino-embryonic antigen 25T/Ibhokisi Cea ng/ml 2-500 5

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     


  • Ngaphambili:
  • Okulandelayo: